vimarsana.com

Page 6 - சிஇஆர்இஎஸ் கையகப்படுத்தல் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovative Industrial Properties (IIPR) Q4 2020 Earnings Call Transcript

Innovative Industrial Properties (IIPR) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Innovative Industrial Properties (NYSE: IIPR) Q4 2020 Earnings Call Wolfe, please go ahead. Vice President, Secretary, and General Counsel Thank you for joining the call. Presenting today are Alan Gold, executive chairman; Paul Smithers, president and chief executive officer; Catherine Hastings, chief financial officer; and Ben Regin, vice president of investments. Before we begin, I d like to remind everyone that statements made during today s conference call may be deemed forward-looking statements within the meaning of the safe harbor of the Private Securities Litigation Reform Act of 1995, and actual results may differ materially due to a variety of risks, uncertainties and other factors. For a detailed discussion of some of the ongoing risks and uncertainties of the company s business, I refer

BevCanna Enterprises (BVNNF), Ceres Acquisition (CERAF), Fire & Flower Holdings (FFLWF), INDIVA LTD by Indiva Ltd (NDVAF), Red White & Bloom Brands (RWBYF), Scotts Miracle-Gro Company (SMG), S&P Dep Receipts (SPY), Twitter (TWTR) - The Week In Cannabis: Stock Volatility, NJ, $1 9B IPO, Policy Moves, Financings, And More

This week, cannabis stocks experienced quite a bit of volatility amid a slew of big news items. On Monday, New Jersey Gov. Phil Murphy signed a trio of adult-use cannabis reform bills, making recreational marijuana legal and regulated for adults 21 years and older, while also decriminalizing the possession among all inhabitants of the state. Following the news, Cantor Fitzgerald analyst Pablo Zuanic recommended investors to keep an eye on three companies with a large presence in the Garden State   Curaleaf Holdings Inc. (OTCQX: CURLF), Green Thumb Industries Inc. (OTCQX:GTBIF) and Columbia Care Inc. (OTCQX:CCHWF). Also this week, Parallel CEO and chewing gum billionaire William “Beau” Wrigley Jr. confirmed the company will go public via a $1.9 billion merger with

The GW Pharma and Parallel Transactions: Where Does the Future of Cannabis go From Here?

This month, two groundbreaking deals in cannabis were announced the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals and the combination of the multi-state operator (MSO) Parallel with the special purpose acquisition company (SPAC), Ceres Acquisition Corp. The proximity of two such large deals in one month begs the question:  Are the GW Pharma Jazz and Ceres Parallel deals an important barometer to the direction of cannabis, both in North America and abroad?  In His Genes The biopharma influence on the cannabis sector started early with the drive toward adoption of current Good Manufacturing Practice (cGMP), the use of high-pressure liquid chromatography (HPLC) for testing and extraction technology for producing concentrates. David Traylor, founder and senior. managing director of Golden Eagle Partners (GEP) was well prepared for the evolution of biotechnologies in marijuana and hemp due to his previous experiences.

Parallel to Go Public via SPAC in $1 8 Billion Deal

Florida-headquartered cannabis firm Parallel will go public on Canada’s NEO Exchange in a SPAC deal valuing the firm at more than $1.8 billion.The multistate cannabis operator led by William “Beau” Wrigley, the billionaire heir to the iconic namesake chewing gum enterprise will merge with Ceres Acquisition Corp., a blank check company backed by music industry entrepreneur Scooter.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.